Companies › PMVP
PMV PHARMACEUTICALS INC (PMVP)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001699382 · EDGAR filings · Updated 2026-07-28
PMV PHARMACEUTICALS INC (PMVP) has reported institutional ownership of 69.3%, with 69 institutional managers holding positions valued at $45.8M per the latest 13F reporting period.
Filings this week (1)
- 2026-07-28 — SCHEDULE 13G/A filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-10 — SCHEDULE 13G/A filed
- 2026-06-05 — Insider transaction reported (Form 4)
- 2026-06-05 — Insider transaction reported (Form 4)
- 2026-06-05 — Insider transaction reported (Form 4)
- 2026-06-05 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, PMV PHARMACEUTICALS INC has 69 institutional holders and institutional ownership of 69.3%.
Insider activity
Insiders reported 7 transactions (0 buys, 6 sells) across 6 reporting insiders, with a net reported value of −$2.57M.
Related companies
CARLSMED INC (CARL) · Assertio Holdings Inc (ASRT) · MAXCYTE INC (MXCT) · Oramed Pharmaceuticals Inc (ORMP) · CARTESIAN THERAPEUTICS INC (RNAC) · ATYR PHARMA INC (ATYR)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.